News

Shalby Limited submitted a certificate to the National Stock Exchange of India Ltd and BSE Limited, received from KFin Technologies Limited, its Registrar and Share Transfer Agent, concerning the dematerialized/rematerialized securities for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Shalby Limited informed the National Stock Exchange of India Ltd and BSE Limited that the trading window for dealing in the company`s securities will be closed from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half year ended September 30, 2026.

Shalby Limited informed the National Stock Exchange of India Ltd and BSE Limited that an ordinary resolution to appoint Mr. Shanay Vikram Shah (DIN:02726541) as Director and Whole Time Director was not approved by shareholders at the company’s 22nd Annual General Meeting on September 11, 2026, resulting in his automatic cessation from the position effective September 10, 2026; he will continue to serve as President of Shalby Limited.

Shalby Medtech Limited announced that Deepak Anand has resigned as Chief Executive Officer, effective close of business hours on September 4, 2026, to move abroad for personal reasons, according to a regulatory filing by Shalby Limited on August 18, 2026.

Shalby has revised the meeting of the Board of Directors which was scheduled to be held on 5 August 2026. The meeting will now be held on 12 August 2026.